Cargando…

Clinical Utility of Protein Induced by Vitamin K Absence-II in Patients with Hepatocellular Carcinoma

OBJECTIVE: Despite moderate sensitivity, alpha fetoprotein (AFP) is widely used in screening and prognostication for hepatocellular carcinoma (HCC). The objective of the current study was to assess clinical utility of Prothrombin induced by Vitamin K absence-II (PIVKAII) in addition to AFP in patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhatti, Abu Bakar H, Naz, Kiran, Abbas, Ghazanfar, Khan, Nusrat Y, Zia, Haseeb H, Ahmed, Imran N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418849/ https://www.ncbi.nlm.nih.gov/pubmed/34181327 http://dx.doi.org/10.31557/APJCP.2021.22.6.1731

Ejemplares similares

When to call it off: defining transplant candidacy limits in liver donor liver transplantation for hepatocellular carcinoma
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2020)

Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2021)

Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
por: Yang, Yang, et al.
Publicado: (2021)

Outcomes of hepaticojejunostomy for post-cholecystectomy bile duct injury
por: Ahmad, Humaid, et al.
Publicado: (2023)

Clinical Profile and Treatment of Hepatocellular Carcinoma: A Single-Center Experience
por: Bhatti, Abu B. H., et al.
Publicado: (2021)

Recipient Outcomes with Younger Donors Undergoing Living Donor Liver Transplantation
por: Dar, Faisal S, et al.
Publicado: (2019)

Living donor liver transplantation for intra hepatic cholangiocarcinoma
por: Hafeez Bhatti, Abu Bakar, et al.
Publicado: (2020)

Living Donor Liver Transplantation During the COVID-19 Pandemic: an Evolving Challenge
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2021)

Prognostication of Learning Curve on Surgical Management of Vasculobiliary Injuries after Cholecystectomy
por: Hafeez Bhatti, Abu Bakar, et al.
Publicado: (2016)

Cutoff values of protein induced by vitamin K absence or antagonist II for diagnosing hepatocellular carcinoma
por: Jang, Tyng-Yuan, et al.
Publicado: (2022)

Performance of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) for Hepatocellular Carcinoma Screening in Chinese Population
por: Yu, Rentao, et al.
Publicado: (2015)

Textbook outcome among voluntary donors undergoing major living donor hepatectomy
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2022)

Inflammatory Hepatocellular Adenoma with Elevated Serum Protein Induced by Vitamin K Absence/Antagonist-II in Adult Males
por: Koya, Yudai, et al.
Publicado: (2019)

Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma
por: Wang, Xiumei, et al.
Publicado: (2017)

Liver transplantation for hepatocellular carcinoma: Improving eligibility without compromising outcomes
por: Hafeez Bhatti, Abu Bakar, et al.
Publicado: (2021)

Protein Induced by Vitamin K Absence or Antagonist-II Versus Alpha-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
por: Kobeissy, Abdallah, et al.
Publicado: (2023)

Living Donor Liver Transplantation for Hepatocellular Carcinoma: Appraisal of the United Network for Organ Sharing Modified TNM Staging
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2021)

Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation
por: Bae, Hyun-Mi, et al.
Publicado: (2011)

Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Perne, Mirela Georgiana, et al.
Publicado: (2023)

Protein Induced by Vitamin K Absence II (PIVKA-II) as a potential serological biomarker in pancreatic cancer: a pilot study
por: Tartaglione, Sara, et al.
Publicado: (2019)

Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma
por: Jang, Eun Sun, et al.
Publicado: (2016)

Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma
por: Wang, Qiang, et al.
Publicado: (2019)

Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma
por: Wang, Guangrong, et al.
Publicado: (2020)

Diagnostic Value of Combined Detection via Protein Induced by Vitamin K Absence or Antagonist II, Alpha-Fetoprotein, and D-Dimer in Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Peng, Fang, et al.
Publicado: (2022)

Prognostic value of preoperative protein-induced vitamin K absence or antagonist II after liver resection for hepatitis B-related hepatocellular carcinoma: a nationwide multicenter study
por: Byun, Dahn, et al.
Publicado: (2022)

Survival after extended resections for gallbladder cancer
por: Bhatti, Abu Bakar Hafeez, et al.
Publicado: (2023)

Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to α-fetoprotein
por: Cui, R, et al.
Publicado: (2003)

Hepatocellular Carcinoma in Pakistan: National Trends and Global Perspective
por: Hafeez Bhatti, Abu Bakar, et al.
Publicado: (2016)

Best achievable results need territorial familiarity: Impact of living donor liver transplant experience on outcomes after pancreaticodoudenectomy
por: Bhatti, Abu Bakar H., et al.
Publicado: (2020)

Efficacy and safety of sorafenib plus vitamin K treatment for hepatocellular carcinoma: A phase II, randomized study
por: Haruna, Yoshimichi, et al.
Publicado: (2021)

Piscine Vitamin D Receptors Vdra/Vdrb in the Absence of Vitamin D Are Utilized by Grass Carp Reovirus for Promoting Viral Replication
por: Song, Yun Jie, et al.
Publicado: (2023)

Vitamin K Contents in Liver Tissue of Hepatocellular Carcinoma Patients
por: Miyakawa, Takayuki, et al.
Publicado: (2000)

The Utility of Gallbladder Absence on Ultrasound for Children With Biliary Atresia
por: Ho, Andrea, et al.
Publicado: (2021)

Protein Induced by Vitamin K Absence II: A Potential Biomarker to Differentiate Pancreatic Ductal Adenocarcinoma from Pancreatic Benign Lesions and Predict Vascular Invasion
por: Yang, Yang, et al.
Publicado: (2023)

Clinical Impact of Vitamin K Dosing on Sorafenib Treatment for Hepatocellular Carcinoma
por: Haruna, Yoshimichi, et al.
Publicado: (2017)

Frequency of Vitamin D Deficiency in Patients of Asthma
por: Alvi, Souhaib, et al.
Publicado: (2021)

Influence of ABCB1 gene polymorphism on concentration to dose ratio and adverse effects of tacrolimus in Pakistani liver transplant recipients
por: Azam, Fahad, et al.
Publicado: (2021)

Effect of CYP3A4 and PPARA polymorphism on concentration-to-dose ratio and adverse effects of tacrolimus in Pakistani liver transplant recipients
por: Azam, Fahad, et al.
Publicado: (2022)

Profiles of Whole Blood Transfusion Recipients at a Teaching Hospital in Lahore, Pakistan
por: Haseeb Khan, Sana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_675gstdcfl8vc2ddmgn03qe8hf